Abiopharma

🔍 AGUIRRE FERNANDO (Director)

Company: Synchrony Financial (SYF)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 14 shares of Dividend Equivalent Unit at $80.75 per share (Direct)
  Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 30,273.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: H | nature_of_ownership: By Family Trusts | shares_owned_after: 15,300.00

Footnotes:

• F1: Represents dividend equivalent units accrued on August 17, 2026 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.
• F2: Balance adjusted to account for rounding of fractional shares over time.